Specific immunotherapy : clinical experience with recombinant molecular major allergens and hypoallergenic variants

Currently, preparations containing native allergens or allergoids are used predominantly in allergen-specific immunotherapy (SIT) of inhaled allergies. The safety and efficacy of these preparations has been demonstrated. However, their reproducible production and standardisation requires substantial...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:HNO 2013-10, Vol.61 (10), p.834-842
Hauptverfasser: Schendzielorz, P, Klimek, L
Format: Artikel
Sprache:ger
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!